Liothyronine Sodium Tablets — Class III drug recall D-318-2013
Terminated recall by L. Perrigo Co., reported 2013-05-15, distributed nationwide. Failed Impurities/Degradation Specifications: 3 month stability testing.
| Recall number | D-318-2013 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | L. Perrigo Co., Allegan, MI, United States |
| Recall initiated | 2013-03-12 |
| Classified | 2013-05-09 |
| Reported by FDA | 2013-05-15 |
| Terminated | 2013-07-24 |
| Distributed | Nationwide (US) |
| Quantity | 21,667 bottles |
| Reason classes | specification failure |
| NDC | 00574-0220-01 |
Product
Liothyronine Sodium Tablets, USP, 5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc., Minneapolis, MN 55427, NDC 0574-0220-01,
Reason for recall
Failed Impurities/Degradation Specifications: 3 month stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-318-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.